Supplementary Figure 2. Validation of HOXD9 genes identified by RNAseq. (a) IOSE11-DNp53 and (b)
FT246 models. The ratio of gene expression in HOXD9 OE cells compared to GFP expressing cells is shown, measured by RNAseq and RT-qPCR, performed using TaqMan gene expression probes.
Supplementary Table 1.
The forty-seven HGSOC risk SNPs used in the eQTL analyses. rs2268177  1  22415410  rs4335340  1  38098035  rs140656631  1  152076102  rs147001887  1  233131754  rs6755777  2  177043226  rs10172595  2  232387063  rs113156482  3  27385515  rs149825468  3  79402822  rs62274042  3  156435952  rs17329882  4  119949960  chr4:185470586:I  4  185470586  rs10069690  5  1279790  rs463548  5  54491914  rs74959519  5  84618055  chr5:164862654:I  5  164862654  rs143589614  5  175418049  rs80077411  6  595273  rs115344852  6  28486098  rs187759744  6  32539152  rs7763414  6  151405377  rs62430802  7  929439  rs1881116  7  1053958  rs62451762  7  7108188  rs76837345  8  82668818  rs10088218  8  129543949  rs4631563  9  16913286  chr9:136138765:D  9  136138765  rs1802669  10  21827796  rs16937956  11  8404501  rs11024093  11  16992395  rs10501153  11  36386755  chr11:86642872:I  11  86642872  rs9559508  13  109805793  rs1315145  14  33846320  chr14:42173641:I  14  42173641  rs71402493  16  10620039  rs4785001  16  58964191  rs75846557  16  62734617  rs4782985  16  84537527  chr17:29181220:I  17  29181220  rs757210  17  36096515  rs146746174  17  43569909  rs7207826  17  46500673  rs78013533  17  60480968  rs4808075  19  17390291  rs6026492  20  57330569  rs6005807  22  28934313 Supplementary 
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Supplementary Methods
Summary of data sets Genetic association analyses were carried out using data from several OCAC genotyping projects. The following numbers are for samples of European ancestry determined using genotype data. These included 2,162 cases and 2,564 controls from a GWAS from North America ("US GWAS"), 1,763 cases and 6,118 controls from a UK-based GWAS ("UK GWAS"), and 441 cases and 442 controls from a second GWAS from North America ("Mayo GWAS") 1-3. 11,030 cases and 21,693 controls from 41 OCAC studies were genotyped using the iCOGS array ("OCAC-iCOGS" stage 1 data). The US and UK GWASs comprised several independent case-control studies, and samples from some of these studies were also subsequently genotyped using the iCOGS array -all duplicates were removed from the analysis. Further details of the component studies are in Supplementary Table 3 . Details of genotyping platform used for each data set are shown in Supplementary Table 4 . All patient samples were collected with informed patient consent and under the approval of the institutional review board overseeing each study. Genotype data quality control UK GWAS: Cases were from four studies (RMH, SEA, UKO and UKR) genotyped using the Illumina 610 Quad array. Controls were blood donor controls and 1958 Birth Cohort controls genotyped on the Illumina 550k array as part of the Welcome Trust Case-Control Consortium. Quality control criteria were applied separately to the case and control sets because they were genotyped separately. SNPs exclusion criteria were: deviation of genotype frequencies from those expected under Hardy-Weinberg equilibrium at P < 10-4, MAF < 1 per cent, MAF between 1 and 5 per cent and call rate < 99 per cent, MAF > 5 per cent and call rate < 95 per cent and test for trend by genotype between the two control sets was significant at P < 10-4. In a union between to two data sets 507,094 SNPs passed QC. US GWAS: Four case controls studies (MAY, NCO, TBO and TOR) were genotyped using the Illumina 660K array, the NEC case-control study was genotyped using the Illumina 370k and Illumina 317K array and the POL case control study was genotyped using the Illumina 550k array. QC was carried out seperately for the three data sets. SNPs exclusion criteria were: deviation of genotype frequencies from thise expected under Hardy-Weinberg equilibrium at P < 10-5, MAF < 1 per cent, MAF between 1 and 5 per cent and call rate < 99 per cent, MAF > 5 per cent and call rate < 95 per cent. 
